Baranwal Drug Private Limited
About Baranwal Drug Private Limited
Data last updated:
Baranwal Drug Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 05 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2019PTC353430. Its GSTIN is 07AAICB5762F1ZM (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Priti Barnwal and Surendra Prasad Barnwal.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 25 Naresh Park Extn.Nangloi, New Delhi, Delhi, India – 110041.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Baranwal Drug Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressA – 25 Naresh Park Extn.Nangloi, New Delhi, Delhi, India – 110041
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Baranwal Drug Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Baranwal Drug is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
Financials of Baranwal Drug Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Baranwal Drug Private Limited, buy the company report.
Board of directors of Baranwal Drug Private Limited
Baranwal Drug has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Priti Barnwal Also directs: Jangliram International Private Limited, Holistic Unique Bharat Private Limited, Steelzet Bharat Private Limited and 5 more | Director | 22 Feb 2024 | 2 Years 8 Months | Current |
| Surendra Prasad Barnwal | Director | 05 Aug 2019 | 7 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Baranwal Drug Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Baranwal Drug Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Baranwal Drug has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAICB5762F1ZM | Delhi | Active | 26 Sep 2019 |
To see the full GST registrations and return filing status of Baranwal Drug Private Limited, buy the company report.
Recent activity
Baranwal Drug Private Limited has 5 board changes on record since 2019: 2 appointments and 3 cessations. The latest: Priti Barnwal ceased to be Additional Director on 27 Sep 2024.
Frequently asked questions
Baranwal Drug is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 05 August 2019 (7+ years old) and is registered under CIN U24100DL2019PTC353430.
Baranwal Drug has 2 current directors:
- Priti Barnwal - Director
- Surendra Prasad Barnwal - Director
The latest financial statements of Baranwal Drug on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Baranwal Drug is 07AAICB5762F1ZM, registered in Delhi.
The CIN (Corporate Identification Number) of Baranwal Drug is U24100DL2019PTC353430. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Baranwal Drug was incorporated on 05 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Delhi.
Priti Barnwal ceased to be Additional Director on 27 Sep 2024. Priti Barnwal was appointed as Director on 22 Feb 2024. Santosh Kumar Barnwal ceased to be Director on 22 Feb 2024. Baranwal Drug has 5 board changes on record in total.
The registered office of Baranwal Drug is at A – 25 Naresh Park Extn.Nangloi, New Delhi, Delhi, India – 110041.
Baranwal Drug operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Baranwal Drug is compliant as of 19 August 2026. The company is actively filing with the Registrar of Companies.